Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011)

被引：69
作者：
Jones, Ronald N. [1 ]
Sader, Helio S. [1 ]
Mendes, Rodrigo E. [1 ]
Flamm, Robert K. [1 ]
机构：
[1] JMI Labs, N Liberty, IA 52317 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2013年 / 75卷 / 01期
关键词：
S; pneumoniae; Resistance; Ceftaroline; Vaccines;
D O I：
10.1016/j.diagmicrobio.2012.08.024
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
A 14-year longitudinal survey of Streptococcus pneumoniae (18,911) strains by the SENTRY Antimicrobial Surveillance Program shows significant increases in resistance to amoxicillin/clavulanate (18.9%), penicillin at a MIC of >= 4 mu g/mL (14.8%), and ceftriaxone (11.7%) among 2011 isolates. Fluoroquinolones (levofloxacin; 98.8% susceptible) and ceftaroline (99.1-100.0% susceptible depending on breakpoint criteria) exhibited high levels of potency, as did linezolid, tigecycline, and vancomycin (100.0%). In summary, resistance rates to several antimicrobials continue to rise after introductions of both pneumococcal conjugate vaccines, as noted from these results for 1998 through 2011. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：107 / 109
页数：3
相关论文
共 15 条
  • [1] [Anonymous], 2012, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically
  • [2] Approved Standard-Ninth
  • [3] [Anonymous], TEFLARO PACKAGE INSE
  • [4] [Anonymous], ASM MAY 21 25 2007 T
  • [5] Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
    Chen, DK
    McGeer, A
    de Azavedo, JC
    Low, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) : 233 - 239
  • [6] Clinical and Laboratory Standards Institute, 2020, Performance Standards for Antimicrobial Susceptibility Testing
  • [7] Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled-Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community-Acquired Pneumonia
    File, Thomas M., Jr.
    Low, Donald E.
    Eckburg, Paul B.
    Talbot, George H.
    Friedland, H. David
    Lee, Jon
    Llorens, Lily
    Critchley, Ian
    Thye, Dirk
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 51 (12) : 1395 - 1405
  • [8] Increased Penicillin Nonsusceptibility of Nonvaccine-Serotype Invasive Pneumococci Other than Serotypes 19A and 6A in Post-7-Valent Conjugate Vaccine Era
    Gertz, Robert E.
    Li, Zhongya
    Pimenta, Fabiana C.
    Jackson, Delois
    Juni, Billie A.
    Lynfield, Ruth
    Jorgensen, James H.
    Carvalho, Maria da Gloria
    Beall, Bernard W.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (05) : 770 - 775
  • [9] Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States
    Jacobs, Michael R.
    Good, Caryn E.
    Windau, Anne R.
    Bajaksouzian, Saralee
    Biek, Donald
    Critchley, Ian A.
    Sader, Helio S.
    Jones, Ronald N.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2716 - 2719
  • [10] Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study
    Jones, Ronald N.
    Farrell, David J.
    Mendes, Rodrigo E.
    Sader, Helio S.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 : III69 - III80
12